Stentless valves may be an alternative to conventional stented bioprostheses and homografts. From all tissue valves homografts proved to have the best long term results. But homografts are not always available. Stentless bioprostheses are similar to homografts concerning in implantation technique, valve anatomy and physiologic function. The stentless design leads to remodeling of the left ventricle and the aortic root, resulting in a superior hemodynamic profile. Nevertheless long term results are required.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Total autologous reconstruction of the right and left ventricular outflow tracts: the case for the modified Ross-Ozaki procedure.
Multimed Man Cardiothorac Surg
January 2025
Department of Cardiothoracic Surgery, Faculty of Medicine, Mansoura University Mansoura, Egypt.
The Ross procedure continues to be the best procedure to address unrepairable aortic valve pathology, especially in young adults. The Achilles heel of this procedure has been aortic root dilation and the potential need for a reoperation that may be associated with slightly increased risks in addition to the need for intervention on the pulmonary outflow tract. Modifying the Ross procedure by autograft inclusion inside a Dacron graft seems to have the potential advantage of stabilizing the autograft diameter, which may be associated with improved durability and decrease the need for future intervention.
View Article and Find Full Text PDFDecellularized aortic homografts versus mechanical composite grafts for aortic root replacement.
Eur J Cardiothorac Surg
August 2024
Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Objectives: Mechanical composite valve grafts (MCVGs) are the first-line therapy for aortic root replacement in young adults. Decellularized aortic homografts (DAH) present a promising novel alternative due to their lower thrombogenicity. We aimed to compare both treatment options regarding survival and valve-related adverse events.
View Article and Find Full Text PDFAortic valved homograft degeneration: surgical or transcatheter approach for repeat aortic valve replacement?
Eur J Cardiothorac Surg
July 2024
Department of Cardiology, LMU University Hospital, Munich, Germany.
Objectives: Aortic valved allografts (homografts) have been used alternatively to mechanical or biological valve prostheses in expectation of better durability; however, homograft valves do degenerate, and redo procedures have proven challenging due to heavy wall calcification. The aim of the study was to compare the outcome of open surgical (SAVR) and transcatheter aortic valve replacement (TAVR) in degenerated homografts.
Methods: Between 1993 and 2022, 81 patients underwent repeat aortic valve procedures having previously received an aortic homograft.
Decellularized aortic allografts for aortic valve replacement: same song, second verse?
Eur J Cardiothorac Surg
June 2024
Department of Cardiothoracic Surgery, Baylor Scott & White The Heart Hospital, Plano, TX, USA.
The Ongoing Debate: Longevity of Biological Valves in Pulmonary Position.
Thorac Cardiovasc Surg
January 2024
Bereich Kinderherzchirurgie/Chirurgie angeborener Herzfehler, Klinik für Kinderherzmedizin und Erwachsene mit angeborenen Herzfehlern, Universitäres Herz- und Gefäßzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Article Synopsis
- The study investigates factors affecting the durability of biological valves used in patients with tetralogy of Fallot (ToF) over a follow-up period of nearly a decade.
- 79 patients aged 0.2 to 56.1 years underwent surgery for valve implantation, with various types of conduits being utilized.
- Results indicate that younger age, smaller valve size, and higher z-scores are linked to decreased valve longevity, emphasizing patient age as a key factor in graft lifespan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!